NISHIBORI; Masahiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for NISHIBORI; Masahiro.The latest application filed is for "antibody-drug conjugates and use of antibodies for drug delivery".

Company Profile

1.6.14

NISHIBORI; Masahiro - Okayama JP
Nishibori; Masahiro - Tokyo JP
Nishibori; Masahiro - Okayama-shi JP
Nishibori; Masahiro - Okayama-ski JP
Nishibori; Masahiro - Tokyo 106 JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody-drug Conjugates And Use Of Antibodies For Drug Delivery App 20220111063 - NISHIBORI; Masahiro ; et al.	2022-04-14
Reactive Oxygen Production Inhibitor And/or Scavenging Promoter App 20210198317 - NISHIBORI; Masahiro ; et al.	2021-07-01
Novel Monoclonal Antibody Having Anti-inflammatory Action App 20210198382 - NISHIBORI; Masahiro ; et al.	2021-07-01
Agent For Enhancing Phagocytosis Ability Of Neutrophils App 20210196787 - NISHIBORI; Masahiro ; et al.	2021-07-01
Gene Expression Cassette And Product Thereof App 20180265894 - Sakaguchi; Masakiyo ; et al.	2018-09-20
Therapeutic agent, method of treatment and method for predicting the severity of systemic inflammatory response syndrome (SIRS), diseases caused or accompanied by neutrophil activation Grant 9,696,321 - Kuroda , et al. July 4, 2	2017-07-04
Humanized anti-HMGB1 antibody or antigen-binding fragment thereof Grant 9,550,825 - Takada , et al. January 24, 2	2017-01-24
Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils Grant 9,504,731 - Nishibori , et al. November 29, 2	2016-11-29
Therapeutic Agent, Method Of Treatment And Method For Predicting The Severity Of Systemic Inflammatory Response Syndrome (sirs), Diseases Caused Or Accompanied By Neutrophil Activation App 20160146835 - KURODA; Kosuke ; et al.	2016-05-26
Character String Selecting Apparatus, Character String Selecting Method, And Computer-readable Medium Storing Character String Selecting Program App 20160041703 - Nishibori; Masahiro	2016-02-11
Therapeutic Agent, Treatment Method And Inspection Method For Diseases Caused By Activation Or Neutrophils App 20150141322 - Nishibori; Masahiro ; et al.	2015-05-21
Suppressant For Atherosclerosis App 20120183556 - Nishibori; Masahiro ; et al.	2012-07-19
Method of preventing cerebral vasospasm with anti-HMGB1 antibody Grant 8,071,098 - Nishibori , et al. December 6, 2	2011-12-06
Cerebral edema suppressant App 20100172909 - Nishibori; Masahiro ; et al.	2010-07-08
Cerebral Infarction Suppressant App 20090252739 - Nishibori; Masahiro ; et al.	2009-10-08
Cerebral Vasospasm Inhibitor App 20090175878 - Nishibori; Masahiro ; et al.	2009-07-09
Cerebral Infarction Suppressant App 20080039500 - Adachi; Naoto ; et al.	2008-02-14
Input processing system for characters Grant 5,977,948 - Nishibori November 2, 1	1999-11-02
System for changing modes and cursor appearance by a single button Grant 5,850,212 - Nishibori December 15, 1	1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.